Forward West: The Forested Watersheds At-risk Decision Support Tool for the Western Us

2007 ◽  
Vol 2007 (5) ◽  
pp. 11-23
Author(s):  
R. Dwight Atkinson ◽  
Bill Cooter ◽  
Tyler Waring ◽  
Aaron Parks
2016 ◽  
Vol 56 ◽  
pp. 43-49 ◽  
Author(s):  
Fernando A. Wilson ◽  
Ozgur M. Araz ◽  
Ronald W. Thompson ◽  
Jay L. Ringle ◽  
W. Alex Mason ◽  
...  

Author(s):  
Alexander Rittel ◽  
Krista Highland ◽  
Mark S Maneval ◽  
Archie Bockhorst ◽  
Agustin Moreno ◽  
...  

Abstract Disclaimer In an effort to expedite the publication of articles related to the COVID-19 pandemic, AJHP is posting these manuscripts online as soon as possible after acceptance. Accepted manuscripts have been peer-reviewed and copyedited, but are posted online before technical formatting and author proofing. These manuscripts are not the final version of record and will be replaced with the final article (formatted per AJHP style and proofed by the authors) at a later time. Purpose To describe the development, implementation, and evaluation of a pharmacy clinical decision support tool designed to increase naloxone coprescription among people at risk for opioid overdose in a large healthcare system. Summary The Military Health System Opioid Registry and underlying presentation layer were used to develop a clinical decision support capability to improve naloxone coprescription at the pharmacy point of care. Pharmacy personnel use a patient identification card barcode scanner or manually enter a patient’s identification number to quickly visualize information on a patient’s risk for opioid overdose and medical history related to pain and, when appropriate, receive a recommendation to coprescribe naloxone. The tool was made available to military treatment facility pharmacy locations. An interactive dashboard was developed to support monitoring, utilization, and impact on naloxone coprescription to patients at risk for opioid overdose. Conclusion Initial implementation of the naloxone tool was slow from a lack of end-user awareness. Efforts to increase utilization were, in part, successful owing to a number of enterprise-wide educational initiatives. In early 2020, the naloxone tool was used in 15% of all opioid prescriptions dispensed at a military pharmacy. Data indicate that the frequency of naloxone coprescription to patients at risk for opioid overdose was significantly higher when the naloxone tool was used than when the tool was not used.


Author(s):  
Christos Katrakazas ◽  
Natalia Sobrino ◽  
Ilias Trochidis ◽  
Jose Manuel Vassallo ◽  
Stratos Arampatzis ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document